What is BioLife Solutions's accrued liabilities, current?

BioLife Solutions (BLFS) reported accrued liabilities, current of $3.26M in Q1 2026.

How has BioLife Solutions's accrued liabilities, current changed year-over-year?

BioLife Solutions's accrued liabilities, current decreased by 24.9% year-over-year, from $4.34M to $3.26M.

What is the long-term trend for BioLife Solutions's accrued liabilities, current?

Over 3 years (2022 to 2025), BioLife Solutions's accrued liabilities, current has grown at a 23.2% compound annual growth rate (CAGR), from $3.13M to $5.85M.

BioLife Solutions BLFS Accrued Liabilities, Current

Accrued Liabilities, Current at other companies

DanaherDHR

——

LeMaitre VascularLMAT

——

TEC

Bio-TechneTECH

——

RevvityRVTY

——

Baxter InternationalBAX

——

ArtivionAORT

——

Other financials

Income statement

See full

Revenue$27.5M+24.7%

Gross profit$17.5M+18.2%

Operating income$27.0K+105%

Net income$1.2M+365%

EPS (diluted)$0.02—

Balance sheet

See full

Cash & equivalents$22.8M-65.9%

Total debt$17.4M-35.6%

Total equity$372.2M+5.6%

Total assets$400.9M+1.5%

Cash flow

See full

Operating cash flow-$491.0K-128%

CapEx$167.0K-4.6%

Free cash flow-$658.0K-142%

Valuation

See full

Market cap$1.34B+33.1%

Enterprise value$1.34B+38.1%

P/S13.5×+0.6×

Profitability

See full

Gross margin66.9%—

Operating margin-16.7%—

Net margin-68.7%—

FCF margin-15.9%+18.7pp

Returns & leverage

See full

Return on equity-14.5%-4.7pp

Debt / equity0×0.0×

Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's accrued liabilities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioLife Solutions's accrued liabilities, current?: BioLife Solutions (BLFS) reported accrued liabilities, current of $3.26M in Q1 2026.
How has BioLife Solutions's accrued liabilities, current changed year-over-year?: BioLife Solutions's accrued liabilities, current decreased by 24.9% year-over-year, from $4.34M to $3.26M.
What is the long-term trend for BioLife Solutions's accrued liabilities, current?: Over 3 years (2022 to 2025), BioLife Solutions's accrued liabilities, current has grown at a 23.2% compound annual growth rate (CAGR), from $3.13M to $5.85M.